Investments
104Portfolio Exits
47About CDP Capital
CDP Capital is a privately-owned investment manager. The firm provides its services to institutions, corporations, public and private pension plans, insurance plans, and public bodies across the globe. Through its subsidiaries, it manages equity, real estate, and private equity portfolios. The firm operates as a subsidiary of Caisse de Depot et Placement du Quebec.

Want to inform investors similar to CDP Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest CDP Capital News
Nov 4, 2016
06 Aug, 2002, 01:00 ET from HyRadix Inc. DES PLAINES, Ill., Aug. 6 /PRNewswire/ -- HyRadix Inc. has announced that CDP Capital - Technology Ventures (formerly CDP Sofinov) of Montreal, Quebec, Canada has become an investor in the company. This investment will allow HyRadix to fully commercialize its fuel processor, which converts either natural gas or LPG into hydrogen for use in residential and small commercial fuel cells "Bringing on an investor like CDP Capital - Technology Ventures is a testament to our company's capabilities and a confirmation of our business strategies," said Robert Gray, HyRadix's President and CEO. "Elements of the Hydrogen Burner technology acquired as a result of CDP Capital Technology Ventures' investment will accelerate our fuel processor commercialization effort, and we are very excited to be receiving it." "The market entry strategies of HyRadix stands out," said Denis Dionne, President, CDP Capital - Technology Ventures, "and we believe HyRadix has the capability to bring to market viable commercial technology in both the fuel cell and small industrial hydrogen markets." About HyRadix HyRadix Inc. is a developer and supplier of hydrogen generation technology to the fuel cell and small industrial markets. Using an innovative combination of technology and equipment, the HyRadix fuel processor efficiently and reliably produces a hydrogen-rich gas from natural gas or LPG. HyRadix has fuel processor technology designed for both residential and commercial polymer electrolyte membrane (PEM) fuel cell applications, as well as for fueling stations and industrial applications. HyRadix also has the intellectual property of the Hydrogen Burner Technology (HBT) company. HyRadix's investors include UOP LLC, Sud-Chemie Inc., and CDP Capital - Technology Ventures. For more information: www.HyRadix.com About CDP Capital - Technology Ventures CDP Capital - Technology Ventures (formerly CDP Sofinov), a member of CDP Capital, invests in innovative companies with promising leading-edge technologies. It also develops partnerships with venture capital funds in Canada, the United States and Europe. Through its portfolios I and II, CDP Capital - Technology Ventures has invested in about 160 companies and 48 investment funds in biotechnology and life sciences, information technologies and industrial technologies. The market value of the total assets under management by CDP Capital - Technology Ventures is almost CA$1.6 billion. With its second generation of direct investment portfolios that began in 2001, CDP Capital - Technology Ventures manages total commitments of CA$3 billion (US$1.8 billion) entrusted to it by CDP. For more information: www.cdpcapital.com/sofinov/eng MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X84678578 SOURCE HyRadix Inc. DES PLAINES, Ill., Aug. 6 /PRNewswire/ -- HyRadix Inc. has announced that CDP Capital - Technology Ventures (formerly CDP Sofinov) of Montreal, Quebec, Canada has become an investor in the company. This investment will allow HyRadix to fully commercialize its fuel processor, which converts either natural gas or LPG into hydrogen for use in residential and small commercial fuel cells "Bringing on an investor like CDP Capital - Technology Ventures is a testament to our company's capabilities and a confirmation of our business strategies," said Robert Gray, HyRadix's President and CEO. "Elements of the Hydrogen Burner technology acquired as a result of CDP Capital Technology Ventures' investment will accelerate our fuel processor commercialization effort, and we are very excited to be receiving it." "The market entry strategies of HyRadix stands out," said Denis Dionne, President, CDP Capital - Technology Ventures, "and we believe HyRadix has the capability to bring to market viable commercial technology in both the fuel cell and small industrial hydrogen markets." About HyRadix HyRadix Inc. is a developer and supplier of hydrogen generation technology to the fuel cell and small industrial markets. Using an innovative combination of technology and equipment, the HyRadix fuel processor efficiently and reliably produces a hydrogen-rich gas from natural gas or LPG. HyRadix has fuel processor technology designed for both residential and commercial polymer electrolyte membrane (PEM) fuel cell applications, as well as for fueling stations and industrial applications. HyRadix also has the intellectual property of the Hydrogen Burner Technology (HBT) company. HyRadix's investors include UOP LLC, Sud-Chemie Inc., and CDP Capital - Technology Ventures. For more information: www.HyRadix.com About CDP Capital - Technology Ventures CDP Capital - Technology Ventures (formerly CDP Sofinov), a member of CDP Capital, invests in innovative companies with promising leading-edge technologies. It also develops partnerships with venture capital funds in Canada, the United States and Europe. Through its portfolios I and II, CDP Capital - Technology Ventures has invested in about 160 companies and 48 investment funds in biotechnology and life sciences, information technologies and industrial technologies. The market value of the total assets under management by CDP Capital - Technology Ventures is almost CA$1.6 billion. With its second generation of direct investment portfolios that began in 2001, CDP Capital - Technology Ventures manages total commitments of CA$3 billion (US$1.8 billion) entrusted to it by CDP. For more information: www.cdpcapital.com/sofinov/eng MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X84678578 SOURCE HyRadix Inc.
CDP Capital Investments
104 Investments
CDP Capital has made 104 investments. Their latest investment was in GGI International as part of their Unattributed VC on March 3, 2011.

CDP Capital Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
3/24/2011 | Unattributed VC | GGI International | $20.5M | Yes | CDP Capital, and Desjardins | 1 |
11/17/2010 | Series E | SS8 Networks | $12.5M | No | 1 | |
9/13/2010 | Debt - II | CoImmune | $4.85M | No | AAC Capital Partners, Aurora Funds, BD Ventures, CDP Capital, Cordova Ventures, Forbion, GeneChem Therapeutics Venture Fund, Harbinger/Aurora Venture Fund, InterSouth Partners, Japan Asia Investment Group, Kirin Pharma Company, Lumira Ventures, Mizuho Capital, Morningside Ventures, Oakwood Medical Investors, Pacific Horizon Ventures, Sanders Morris Harris Private Equity, Senmed Medical Ventures, Signet Healthcare Partners, Sutter Hill Ventures, TFG Capital Unternehmensbeteiligungsgesellschaft, TVM Capital Life Science, and Vestcorp AG | |
7/14/2010 | Unattributed VC - II | |||||
11/21/2008 | Series C - II |
Date | 3/24/2011 | 11/17/2010 | 9/13/2010 | 7/14/2010 | 11/21/2008 |
---|---|---|---|---|---|
Round | Unattributed VC | Series E | Debt - II | Unattributed VC - II | Series C - II |
Company | GGI International | SS8 Networks | CoImmune | ||
Amount | $20.5M | $12.5M | $4.85M | ||
New? | Yes | No | No | ||
Co-Investors | CDP Capital, and Desjardins | AAC Capital Partners, Aurora Funds, BD Ventures, CDP Capital, Cordova Ventures, Forbion, GeneChem Therapeutics Venture Fund, Harbinger/Aurora Venture Fund, InterSouth Partners, Japan Asia Investment Group, Kirin Pharma Company, Lumira Ventures, Mizuho Capital, Morningside Ventures, Oakwood Medical Investors, Pacific Horizon Ventures, Sanders Morris Harris Private Equity, Senmed Medical Ventures, Signet Healthcare Partners, Sutter Hill Ventures, TFG Capital Unternehmensbeteiligungsgesellschaft, TVM Capital Life Science, and Vestcorp AG | |||
Sources | 1 | 1 |
CDP Capital Portfolio Exits
47 Portfolio Exits
CDP Capital has 47 portfolio exits. Their latest portfolio exit was Grocery Gateway on March 16, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
3/16/2021 | Corporate Majority | 4 | |||
5/2/2019 | IPO | Public | 2 | ||
11/6/2018 | Acquired | 2 | |||
Date | 3/16/2021 | 5/2/2019 | 11/6/2018 | ||
---|---|---|---|---|---|
Exit | Corporate Majority | IPO | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 4 | 2 | 2 |
CDP Capital Acquisitions
1 Acquisition
CDP Capital acquired 1 company. Their latest acquisition was HyRadix on April 09, 2007.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
4/9/2007 | Other Venture Capital | Acquired |
Date | 4/9/2007 |
---|---|
Investment Stage | Other Venture Capital |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired |
Sources |
CDP Capital Team
1 Team Member
CDP Capital has 1 team member, including former Senior Partner, Luc Charron.
Name | Work History | Title | Status |
---|---|---|---|
Luc Charron | Senior Partner | Former |
Name | Luc Charron |
---|---|
Work History | |
Title | Senior Partner |
Status | Former |